Thai PBS Thai PBS
AstraZeneca vaccine benefits increase with age: EMA

AstraZeneca vaccine benefits increase with age: EMA

1 Oct 05:40 Key points summarised by AI
  • The European Medicines Agency (EMA) affirmed that the AstraZeneca COVID-19 vaccine's benefits increase with age and outweigh its risks for adults, despite acknowledging very rare cases of blood clots.
  • The EMA identified rare blood clots occurring in approximately one in 100,000 AstraZeneca recipients, noting that the vaccine is effective in preventing hospitalizations, ICU admissions, and deaths.
  • Pfizer's CEO suggested that a third vaccine dose would likely be required within 12 months, and annual COVID-19 vaccinations might become necessary.
  • The EMA also recommended listing blood clots as a "very rare" side effect for the Johnson & Johnson vaccine, while reiterating that its benefits still outweigh the risks.
  • Public confidence in both AstraZeneca and Johnson & Johnson vaccines has been impacted by the reported links to rare blood clots, prompting some countries to restrict their use.
Read full article
World 1/2
Skip > Skip >